168 related articles for article (PubMed ID: 9114911)
1. Evidence for differences in the binding of drugs to the two main genetic variants of human alpha 1-acid glycoprotein.
Herve F; Gomas E; Duche JC; Tillement JP
Br J Clin Pharmacol; 1993 Sep; 36(3):241-9. PubMed ID: 9114911
[TBL] [Abstract][Full Text] [Related]
2. Binding of disopyramide, methadone, dipyridamole, chlorpromazine, lignocaine and progesterone to the two main genetic variants of human alpha 1-acid glycoprotein: evidence for drug-binding differences between the variants and for the presence of two separate drug-binding sites on alpha 1-acid glycoprotein.
Hervé F; Duché JC; d'Athis P; Marché C; Barré J; Tillement JP
Pharmacogenetics; 1996 Oct; 6(5):403-15. PubMed ID: 8946472
[TBL] [Abstract][Full Text] [Related]
3. The genetic variant A of human alpha 1-acid glycoprotein limits the blood to brain transfer of drugs it binds.
Jolliet-Riant P; Boukef MF; Duché JC; Simon N; Tillement JP
Life Sci; 1998; 62(14):PL219-26. PubMed ID: 9570346
[TBL] [Abstract][Full Text] [Related]
4. Fractionation of the genetic variants of human alpha 1-acid glycoprotein in the native form by chromatography on an immobilized copper(II) affinity adsorbent. Heterogeneity of the separate variants by isoelectrofocusing and by concanavalin A affinity chromatography.
Hervé F; Gomas E; Duché JC; Tillement JP
J Chromatogr; 1993 May; 615(1):47-57. PubMed ID: 8340462
[TBL] [Abstract][Full Text] [Related]
5. Differential binding of disopyramide and warfarin enantiomers to human alpha(1)-acid glycoprotein variants.
Nakagawa T; Kishino S; Itoh S; Sugawara M; Miyazaki K
Br J Clin Pharmacol; 2003 Dec; 56(6):664-9. PubMed ID: 14616427
[TBL] [Abstract][Full Text] [Related]
6. pH titration curves of the desialylated human alpha 1-acid glycoprotein variants by combined isoelectrofocusing-electrophoresis: utilization in the development of a fractionation method for the protein variants by chromatography on immobilized metal affinity adsorbent.
Hervé F; Duché JC; Barré J; Millot MC; Tillement JP
J Chromatogr; 1992 May; 577(1):43-59. PubMed ID: 1400745
[TBL] [Abstract][Full Text] [Related]
7. Lipophilicity Influences Drug Binding to α1-Acid Glycoprotein F1/S Variants But Not to the A Variant.
Hanada K
Drugs R D; 2017 Sep; 17(3):475-480. PubMed ID: 28646384
[TBL] [Abstract][Full Text] [Related]
8. Changes in expression and microheterogeneity of the genetic variants of human alpha1-acid glycoprotein in malignant mesothelioma.
Hervé F; Duché JC; Jaurand MC
J Chromatogr B Biomed Sci Appl; 1998 Sep; 715(1):111-23. PubMed ID: 9792503
[TBL] [Abstract][Full Text] [Related]
9. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
Morse DS; Abernethy DR; Greenblatt DJ
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
[TBL] [Abstract][Full Text] [Related]
10. Glycosylation study of the major genetic variants of human alpha1-acid glycoprotein and of their pharmacokinetics in the rat.
Hervé F; d'Athis P; Tremblay D; Tillement JP; Barré J
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Dec; 798(2):283-94. PubMed ID: 14643508
[TBL] [Abstract][Full Text] [Related]
11. Ligand specificity of the genetic variants of human alpha1-acid glycoprotein: generation of a three-dimensional quantitative structure-activity relationship model for drug binding to the A variant.
Hervé F; Caron G; Duché JC; Gaillard P; Abd Rahman N; Tsantili-Kakoulidou A; Carrupt PA; d'Athis P; Tillement JP; Testa B
Mol Pharmacol; 1998 Jul; 54(1):129-38. PubMed ID: 9658198
[TBL] [Abstract][Full Text] [Related]
12. Comparison of drug binding capacities of two AAG peptidic variants of human origin.
Bree F; Eap CB; Baumann P; Duche JC; Tillement JP
Prog Clin Biol Res; 1989; 300():399-403. PubMed ID: 2780636
[No Abstract] [Full Text] [Related]
13. Imipramine binding to alpha-1-acid glycoprotein in normal subjects and cardiac patients.
Freilich DI; Giardina EG
Clin Pharmacol Ther; 1984 May; 35(5):670-4. PubMed ID: 6713778
[TBL] [Abstract][Full Text] [Related]
14. Two-step chromatographic purification of human plasma alpha(1)-acid glycoprotein: its application to the purification of rare phenotype samples of the protein and their study by chromatography on immobilized metal chelate affinity adsorbent.
Herve F; Millot MC; Eap CB; Duche JC; Tillement JP
J Chromatogr B Biomed Appl; 1996 Mar; 678(1):1-14. PubMed ID: 8861652
[TBL] [Abstract][Full Text] [Related]
15. Binding of amitriptyline to alpha 1-acid glycoprotein and its variants.
Eap CB; Cuendet C; Baumann P
J Pharm Pharmacol; 1988 Nov; 40(11):767-70. PubMed ID: 2907555
[TBL] [Abstract][Full Text] [Related]
16. Comparison of drug binding capacities of three AAG glycan variants of human origin.
Bree F; Rouzeau JD; Durand G; Gardier A; Tillement JP
Prog Clin Biol Res; 1989; 300():405-8. PubMed ID: 2506553
[No Abstract] [Full Text] [Related]
17. Enantioselective binding of disopyramide to alpha1-acid glycoprotein and its variants.
Kishino S; Itoh S; Nakagawa T; Miyazaki K
Eur J Clin Pharmacol; 2001 Oct; 57(8):583-7. PubMed ID: 11758636
[TBL] [Abstract][Full Text] [Related]
18. Study of the expression of the genetic variants of human alpha1-acid glycoprotein in healthy subjects using isoelectric focusing and immunoblotting.
Duché JC; Hervé F; Tillement JP
J Chromatogr B Biomed Sci Appl; 1998 Sep; 715(1):103-9. PubMed ID: 9792502
[TBL] [Abstract][Full Text] [Related]
19. Interaction between antidepressants and alpha 1-adrenergic receptor antagonists on the binding to alpha 1-acid glycoprotein.
Ferry DG; Caplan NB; Cubeddu LX
J Pharm Sci; 1986 Feb; 75(2):146-9. PubMed ID: 2870173
[TBL] [Abstract][Full Text] [Related]
20. Selectivity in the binding of psychotropic drugs to the variants of alpha-1 acid glycoprotein.
Eap CB; Cuendet C; Baumann P
Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):220-4. PubMed ID: 3368020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
